-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Overt hepatic encephalopathy (OHE) causes up to one-third of cirrhotic patients to experience worsening of cirrhotic disease progression at some point in the clinical course
.
HE is also a major factor in repeat hospitalizations in patients with cirrhosis and is associated with a high mortality rate
Overt hepatic encephalopathy (OHE) causes up to one-third of cirrhotic patients to experience worsening of cirrhotic disease progression at some point in the clinical course
The researchers divided patients into four groups; no OHE and infection (n = 352); no infection but OHE (n = 221); no OHE but infection (n = 100) and OHE and infection (n = 100) n = 86)
.
In multivariate analysis, OHE (OR, 1.
Figure: Incidence of Hepatic Encephalopathy
The findings suggest a significant relationship between OHE and the risk of new infections in the context of cirrhosis
.
Therefore, patients with OHE should be considered to be at high risk for new infections, and antibiotics
The findings suggest a significant relationship between OHE and the risk of new infections in the context of cirrhosis
Eman Alabsawy.
Overt hepatic encephalopathy is an independent risk factor for de novo infection in cirrhotic patients with acute decompensation.
Leave a comment here